Gene-editing tool ‘CRISPR’ gaining massive attention – AZFamily
AZFamily |
Gene-editing tool ‘CRISPR‘ gaining massive attention
AZFamily CRISPR (pronounced “crisper”) is a powerful technique for editing DNA. It has received an enormous amount of attention in the scientific and popular press, largely based on the promise of what this powerful gene-editing technology will someday do. Gene Editing May Vanquish Deadly Diseases, But Some See RisksNBCNews.com |
Science News |
Transplanted stem cells become eggs in sterile mice
Science News EGG-CITING DEVELOPMENT Germline stem cells (orange circles, left) implanted into a mouse’s ovary move to the edge of the ovary (middle) and begin developing into eggs. By day 6 (right) the cells began making a protein called STRA8 (pointed out with … |
Science News |
Transplanted stem cells become eggs in sterile mice
Science News EGG-CITING DEVELOPMENT Germline stem cells (orange circles, left) implanted into a mouse’s ovary move to the edge of the ovary (middle) and begin developing into eggs. By day 6 (right) the cells began making a protein called STRA8 (pointed out with … |
Science News |
Transplanted stem cells become eggs in sterile mice | Science News
Science News EGG-CITING DEVELOPMENT Germline stem cells (orange circles, left) implanted into a mouse’s ovary move to the edge of the ovary (middle) and begin … Mouse study looks at safety of stem cell therapy for early menopauseMedical Xpress |
HPCwire (blog) |
NSF, IARPA, and SRC Push into “Semiconductor Synthetic Biology” Computing
HPCwire (blog) Now, the National Science Foundation has fired up a new program – Semiconductor Synthetic Biology for Information Processing and Storage Technologies – and just issued a solicitation in which eight to ten grants totaling around $4 million per year for … |
|
Vaccines Based on Immunotherapies Being Tested in Phase 2 Trials in Brain Cancer
Immuno-Oncology News Immunomic Therapeutics has entered an exclusive licensing agreement with Annias Immunotherapeutics for the rights to use Annia’s intellectual property regarding an immunotherapy based on antigens of cytomegalovirus (CMV). Both companies are … |